Welcome! 閮餃
撠擐 撠曄 撠隢憯 撠刻賣 撠啣

Advanced

Change History

Message: [Report of Honor] First Taiwanese Recipient of SEBM Distinguished Scientist Award

Changed By: techman
Change Date: April 20, 2011 10:43AM

[Report of Honor] First Taiwanese Recipient of SEBM Distinguished Scientist Award
[Report of Honor] First Taiwanese Recipient of SEBM Distinguished Scientist Award (<a href=http://mepopedia.com/forum/read.php?127,11903>Chinese Version</a>)

<i>NCKU News</i> (2011/04/20) Dr. Nan-Shan CHANG, Professor and Chair of the Institute of Molecular Medicine at National Cheng Kung University (NCKU), Tainan, Taiwan, is one of the 9 recipients of the 2011 Distinguished Scientist Award by the US-based Society for Experimental Biology and Medicine (SEBM).

According to the congratulatory letter Dr. CHANG received from the SEBM President Susan E. MULRONEY, the SEBM Distinguished Scientist Award was established in 2010 to honor SEBM members who have made seminal contributions to biomedical research and the advancement of SEBM. Dr. CHANH is the first member from Taiwan receiving the award.

The Society for Experimental Biology and Medicine (SEBM), founded in 1903, is an organization aiming to promote biomedical research and facilitate scientific exchange among disciplines. It currently has 508 members, including 15 members from Taiwan.

Dr. CHANG joined NCKU on November 13, 2006. Since then, he has received 3 highly recognized awards, including Breast Cancer Concept Award from the Department of Defense (DoD) USA in 2008, Neurofibromatosis Research Award from DoD USA in 2010, and the SEBM Award this year.

Dr. CHANG was trained in immunology and received his Ph.D. degree from the Medical University of South Carolina in 1984. He joined the University of Massachusetts Medical Center as a junior faculty in 1987, and became a full-time faculty at the Guthrie Research Institute in Pennsylvania in 1989. Dr. CHANG is most noted for his discovery of a tumor suppressor WW domain-containing oxidoreductase (WWOX) in year 2000. Dr. CHANG has been leading in the field, and invited for lectures and seminars in universities and symposia around the globe for 47 times since then. The WWOX gene plays a crucial role in controlling cancer progression. Alteration of this gene may lead to caner initiation and non-stop growth.


Further Information:
<a href=http://news-en.secr.ncku.edu.tw/files/14-1083-77717,r614-1.php>NCKU News 2010/04/20</a>

Original Message

雿: techman
Date: April 20, 2011 10:42AM

[Report of Honor] First Taiwanese Recipient of SEBM Distinguished Scientist Award
[Report of Honor] First Taiwanese Recipient of SEBM Distinguished Scientist Award (Chinese Version)

NCKU News (2011/04/20) Dr. Nan-Shan CHANG, Professor and Chair of the Institute of Molecular Medicine at National Cheng Kung University (NCKU), Tainan, Taiwan, is one of the 9 recipients of the 2011 Distinguished Scientist Award by the US-based Society for Experimental Biology and Medicine (SEBM).

According to the congratulatory letter Dr. CHANG received from the SEBM President Susan E. MULRONEY, the SEBM Distinguished Scientist Award was established in 2010 to honor SEBM members who have made seminal contributions to biomedical research and the advancement of SEBM. Dr. CHANH is the first member from Taiwan receiving the award.

The Society for Experimental Biology and Medicine (SEBM), founded in 1903, is an organization aiming to promote biomedical research and facilitate scientific exchange among disciplines. It currently has 508 members, including 15 members from Taiwan.

Dr. CHANG joined NCKU on November 13, 2006. Since then, he has received 3 highly recognized awards, including Breast Cancer Concept Award from the Department of Defense (DoD) USA in 2008, Neurofibromatosis Research Award from DoD USA in 2010, and the SEBM Award this year.

Dr. CHANG was trained in immunology and received his Ph.D. degree from the Medical University of South Carolina in 1984. He joined the University of Massachusetts Medical Center as a junior faculty in 1987, and became a full-time faculty at the Guthrie Research Institute in Pennsylvania in 1989. Dr. CHANG is most noted for his discovery of a tumor suppressor WW domain-containing oxidoreductase (WWOX) in year 2000. Dr. CHANG has been leading in the field, and invited for lectures and seminars in universities and symposia around the globe for 47 times since then. The WWOX gene plays a crucial role in controlling cancer progression. Alteration of this gene may lead to caner initiation and non-stop growth.


Further Information:
NCKU News 2010/04/20